Form 4: Nevro Corp Director Karen Prange Reports Acquisition of Restricted Stock Units
SEC Form 4
Director Karen Prange reports acquisition of 19,169 restricted stock units (RSUs) in Nevro Corp, vesting within one year, increasing her total holdings to 33,948 shares.
Summary
- On May 23, 2024, Karen Prange, a director of Nevro Corp, acquired 19,169 restricted stock units (RSUs).
- These RSUs will vest on the earlier of one year from the grant date (May 23, 2024) or the next Annual Meeting following that date, contingent upon continued service to the Issuer.
- Following this transaction, Prange's total holdings include 33,948 shares, inclusive of the 19,169 RSUs.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock units acquisition. The director's acquisition could be seen as a positive sign, but it's a routine transaction.
Positives
- The acquisition of RSUs by a director signals confidence in the company's future performance.
Future Outlook
The vesting of the RSUs is contingent upon the Reporting Person's continued service to the Issuer.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.
Stakeholder Impact
- The acquisition of RSUs by a director may positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of earliest transaction: Acquisition of 19,169 restricted stock units (RSUs). |
| 05/23/2024 | RSUs vest on the earlier of one year from this date or the next Annual Meeting following this date. |
| 05/28/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.